Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, genetic, hemoglobinopathy characterized by generally mild clinical phenotype, high fetal hemoglobin levels and mild microcytosis and hypochromia. In some cases, acute sickle cell disease manifestations were reported, namely acute chest syndrome and acute pain crisis. The genotype is characterized by the combination of an HbS and HbF allele; symptoms depend on the degree of HbF:HbS expressivity with patients with more than 35% pancellular HbF expression being asymptomatic. Symptomatic patients have heterocellular expression of HbF.
Features include always present findings: Persistence of hemoglobin F; and common findings: HbS hemoglobin. 13 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 6 | Persistence of hemoglobin F, HbS hemoglobin, Enlarged spleen (splenomegaly) |
Phenotype severity distribution: 1 always present feature, 1 common feature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for hereditary persistence of fetal hemoglobin-sickle cell disease syndrome.
3 publications have been identified in PubMed for hereditary persistence of fetal hemoglobin-sickle cell disease syndrome. Research spans Case Report / Case Series (100%).
Daniel CE (2025). [PMID: 40084327](https://pubmed.ncbi.nlm.nih.gov/40084327/). *Cureus*. [Case Report / Case Series]
Bokhary M (2025). [PMID: 40777672](https://pubmed.ncbi.nlm.nih.gov/40777672/). *Cureus*. [Case Report / Case Series]
Alnaqbi KA (2024). [PMID: 39113817](https://pubmed.ncbi.nlm.nih.gov/39113817/). *Cureus*. [Case Report / Case Series]
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:33 PM UTC
Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.
Claim this page and your organization will be listed here for patients and families to find.
European rare disease database
Genetic and Rare Diseases Info Center
3 |
Enlarged spleen (splenomegaly), Abdominal pain, Blocked blood flow in the spleen (splenic infarction) |
Eyes | 1 | Damage to the retina (retinopathy) |
Lungs and breathing | 1 | Pulmonary infiltrates |
Bones and joints | 1 | Arthralgia |